ITU Unit Action

SLTX

Sigilon Therapeutics, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	88197578	FILING DATE	11/16/2018
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	MURRAY, GEORGE WILLIAM	L.O. ASSIGNED	N30-NOT FOUND

PUB INFORMATION
RUN DATE	05/21/2020
PUB DATE	04/09/2019
STATUS	731-SECOND EXTENSION - GRANTED
STATUS DATE	05/19/2020
LITERAL MARK ELEMENT	SLTX

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	SLTX
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Sigilon Therapeutics, Inc.
ADDRESS	100 Binney Street, Suite 600 Cambridge, MA 02142
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

GOODS AND SERVICES
INTERNATIONAL CLASS	001
DESCRIPTION TEXT	Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use

INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	001	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
05/21/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	016
05/19/2020	EX2G	S	EXTENSION 2 GRANTED	015
05/19/2020	EXT2	S	EXTENSION 2 FILED	014
05/19/2020	EEXT	I	TEAS EXTENSION RECEIVED	013
11/06/2019	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	012
11/04/2019	EX1G	S	EXTENSION 1 GRANTED	011
11/04/2019	EXT1	S	EXTENSION 1 FILED	010
11/04/2019	EEXT	I	TEAS EXTENSION RECEIVED	009
06/04/2019	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	008
04/09/2019	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	007
04/09/2019	PUBO	A	PUBLISHED FOR OPPOSITION	006
03/20/2019	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	005
02/25/2019	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	004
02/20/2019	DOCK	D	ASSIGNED TO EXAMINER	003
12/04/2018	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
11/20/2018	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Ann Lamport Hammitte
CORRESPONDENCE ADDRESS	Ann Lamport Hammitte LANDO & ANASTASI, LLP 60 State Street, 23rd Floor Boston MA 02109
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Sigilon Therapeutics, Inc.
ADDRESS	100 Binney Street, Suite 600 Cambridge, MA 02142
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.